Market Research Report
Digital Therapeutics Market to 2025- Global Analysis and Forecasts by Application ; Distribution Channel and Geography
|Published by||The Insight Partners||Product code||755832|
|Published||Content info||137 Pages
Delivery time: 1-2 business days
|Digital Therapeutics Market to 2025- Global Analysis and Forecasts by Application ; Distribution Channel and Geography|
|Published: December 3, 2018||Content info: 137 Pages||
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The digital therapeutics market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. The growth of the digital therapeutics market is primarily attributed to the rising pressure on healthcare providers to reduce healthcare costs, rising prevalence of chronic diseases and rising in the number of partnerships and collaborations in the market are the major factors that anticipated to propel the growth for the digital therapeutics market in the forecast period. However, increasing rate of cyber threat and rise in data security issues are expected to act as major challenges hindering the market growth. On the other hand, large number of undiagnosed population is expected to be prevalent future trend in the global digital therapeutics market
Global digital therapeutics market segmented into by application and distribution channel. Based on application, the market is segmented into diabetes, cardiovascular disease, central nervous system disease, respiratory diseases, smoking cessation, musculoskeletal disease, and others. On the basis of distribution channel, the digital therapeutics market classified as patients, providers, payers and employers.
The diabetes segment anticipated to the fastest and largest growing segment in the forecast period. The body's inability to produce or effectively utilize the hormone insulin, caused diabetes. This inability prevents the body from adequately regulating blood glucose levels. Digital therapeutics help to monitor the blood glucose level of patients, which helps in reducing the prevalence of diabetes across the globe. The increasing prevalence of diabetes help to enhance the demand for digital therapeutics that majorly helps in increasing the growth of this market.
The patients segment is expected to be the largest and fastest growing segment in the coming years. The increasing prevalence of diabetes helps to drive the market. Moreover, rise in the number of cases of dementia and Alzheimer's disease also help to upsurge the demand for digital therapeutics in the forecast period.
The digital therapeutics market was estimated through extensive primary and secondary sources that includes a vast array of government authorized websites such as Centers for Disease Control and Prevention (CDC), Habib Medical Group (HMG), Indian Council Of Medical Research (ICMR), International Diabetes Federation (IDF), World Health Organization (WHO) and others. The primary respondents included chair-holders and representatives of the demand and supply side for healthcare industries as well as medical professionals at digital therapeutics device manufacturing companies, hospitals, and research centers.
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the digital therapeutics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the global digital therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution